Article Details

Investors bet on AstraZeneca's experimental breast cancer drug following positive trial

Retrieved on: 2022-10-26 20:50:03

Tags for this article:

Click the tags to see associated articles and topics

Investors bet on AstraZeneca's experimental breast cancer drug following positive trial. View article details on hiswai:

Excerpt

Shares rose in AstraZeneca today on the back of progress made with its breast cancer treatment, which combines its older Faslodex drug with a new.

Article found on: www.cityam.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up